Immatics (IMTX) Capital Expenditures (2019 - 2025)
Immatics (IMTX) reported Capital Expenditures of -$1.1 million for Q4 2025, up 36.88% on a YoY basis from -$824903.9 in Q4 2024, and up 10.98% sequentially from -$1.3 million in Q3 2025.
Immatics (IMTX) Capital Expenditures (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Capital Expenditures data on file, last reported at -$1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures rose 36.88% year-over-year to -$1.1 million; the trailing twelve-month figure through Dec 2025 stood at -$7.2 million (up 58.95% YoY), and the FY2025 full-year result was -$7.4 million, up 57.93% from the prior year.
- Capital Expenditures improved to -$1.1 million in Q4 2025, from -$1.3 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $56.3 million in Q4 2023 to a low of -$11.6 million in Q2 2023.
- A 5-year average of $386663.4 and a median of -$1.6 million in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 545.09% in 2022 and plunged 1248.09% in 2023, its largest moves.
- Tracing IMTX's Capital Expenditures over 5 years: stood at -$2.1 million in 2021, then jumped by 545.09% to $9.3 million in 2022, then surged by 504.3% to $56.3 million in 2023, then tumbled by 103.18% to -$1.8 million in 2024, then soared by 36.88% to -$1.1 million in 2025.
- Business Quant data shows IMTX's Capital Expenditures at -$1.1 million in Q4 2025, -$1.3 million in Q3 2025, and -$1.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Dec 31, 2024 | -1.79 Mn |
| Dec 31, 2024 | -1.79 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -2.82 Mn |
| Jun 30, 2024 | -2.82 Mn |
| Mar 31, 2024 | -9.97 Mn |
| Mar 31, 2024 | -9.97 Mn |
| Dec 31, 2023 | 56.28 Mn |
| Dec 31, 2023 | 56.28 Mn |
| Sep 30, 2023 | -7.08 Mn |
| Sep 30, 2023 | -7.08 Mn |